Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lei Huo

Showing results (181-190 of 222) with videos related to

Pageof 23
Sort By:
Springerplus|October 25, 2013
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinomaSavitri Krishnamurthy, Wendy Woodward, Wei Yang, et al.
Investigational New Drugs|September 28, 2020
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancerClinton Yam, Gaiane M Rauch, Tanbin Rahman, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2024
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancerJangsoon Lee, Kumiko Kida, Jiwon Koh, et al.
European Journal of Radiology|April 22, 2019
Imaging features of triple-negative breast cancers according to androgen receptor statusRosalind P Candelaria, Beatriz E Adrada, Wei Wei, et al.
Cancer Research|December 17, 2014
Gain of glucose-independent growth upon metastasis of breast cancer cells to the brainJinyu Chen, Ho-Jeong Lee, Xuefeng Wu, et al.
Cancer Research|August 1, 2022
MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerChengyue Wu, Angela M Jarrett, Zijian Zhou, et al.
Oncotarget|January 27, 2017
Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarrayHui Chen, Rajesh R Singh, Xinyan Lu, et al.
JCO Precision Oncology|March 14, 2024
Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer SubtypesReva K Basho, Li Zhao, Jason B White, et al.
Human Pathology|April 12, 2022
TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinomaEsther C Yoon, Gang Wang, Bryce Parkinson, et al.
Nature|May 13, 2026
Ecotypes of triple-negative breast cancer in response to chemotherapyYun Yan, Yiyun Lin, Tapsi Kumar, et al.
Pageof 23

Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
Springerplus|October 25, 2013
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinomaSavitri Krishnamurthy, Wendy Woodward, Wei Yang, et al.
Investigational New Drugs|September 28, 2020
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancerClinton Yam, Gaiane M Rauch, Tanbin Rahman, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2024
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancerJangsoon Lee, Kumiko Kida, Jiwon Koh, et al.
European Journal of Radiology|April 22, 2019
Imaging features of triple-negative breast cancers according to androgen receptor statusRosalind P Candelaria, Beatriz E Adrada, Wei Wei, et al.
Cancer Research|December 17, 2014
Gain of glucose-independent growth upon metastasis of breast cancer cells to the brainJinyu Chen, Ho-Jeong Lee, Xuefeng Wu, et al.
Cancer Research|August 1, 2022
MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerChengyue Wu, Angela M Jarrett, Zijian Zhou, et al.
Oncotarget|January 27, 2017
Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarrayHui Chen, Rajesh R Singh, Xinyan Lu, et al.
JCO Precision Oncology|March 14, 2024
Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer SubtypesReva K Basho, Li Zhao, Jason B White, et al.
Human Pathology|April 12, 2022
TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinomaEsther C Yoon, Gang Wang, Bryce Parkinson, et al.
Nature|May 13, 2026
Ecotypes of triple-negative breast cancer in response to chemotherapyYun Yan, Yiyun Lin, Tapsi Kumar, et al.
Pageof 23